Post Marketing Study to Evaluate the Role of CYTOGAM in the Reduction of Risk of Late CMV Disease Following the Conclusion of ...

Kamada begins patient enrolment in an investigator-initiated clinical trial of Cytogam to prevent cytomegalovirus in kidney transplantation: Rehovot, Israel Thursday, November 6, ...

A comprehensive eight-year study examining audiological outcomes of newborns screened for congenital cytomegalovirus (cCMV) ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...

Researchers have identified in a new study that patients suffering from chronic obstructive pulmonary disease (COPD) who ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected revenue range to $1.6 – $2.0 billion Improves 2025 expected GAAP operating ...

Q3 2025 Earnings Call Transcript November 6, 2025 Moderna, Inc. beats earnings expectations. Reported EPS is $-0.51282, expectations were $-2.15. Operator: Good day, and thank you for standing by.

Analysts are expecting Moderna to report revenue of $880 million in the third quarter, according to FactSet. The consensus ...

The controlled multi-centre, randomised, prospective trial is investigating the therapy in kidney transplant recipients.

New study reveals how human astroviruses bind to humans cells and paves the way for new therapies and vaccines ...

Scientists studied hundreds of kids and staff members to learn how respiratory viruses circulate in schools. Here’s what they found, as peak virus season approaches.